Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026)
Neogen (NEOG) posted Liabilities from Discontinued Operations of $6.6 million for Q2 2026, up 3.12% on a QoQ basis from $6.4 million in Q1 2026, and little changed year-over-year from $6.6 million in Q2 2025.
Powered by 
Analysis
Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends
Neogen has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at $6.6 million in Q2 2026.
- On a quarterly basis, Liabilities from Discontinued Operations changed 0.0% year-over-year to $6.6 million in Q2 2026; TTM through May 2026 was $6.6 million, a 0.0% change from a year earlier, with the FY2026 full-year figure at $6.6 million, changed 0.0% from the prior year.
- Liabilities from Discontinued Operations was $6.6 million for Q2 2026 at Neogen, up from $6.4 million in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was $9.1 million in Q4 2025, with the low at $6.4 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 6.60 Mn |
| Feb 28, 2026 | 6.40 Mn |
| Nov 30, 2025 | 9.11 Mn |
| May 31, 2025 | 6.60 Mn |